Dataset Information

The frequency of company-sponsored alcohol brand-related sites on Facebook™-2012.

ABSTRACT: This research provides an estimate of the frequency of company-sponsored alcohol brand-related sites on Facebook™.We conducted a systematic overview of the extent of alcohol brand-related sites on Facebook™ in 2012.We conducted a 2012 Facebook™ search for sites specifically related to 898 alcohol brands across 16 different alcoholic beverage types. Descriptive statistics were produced using Microsoft SQL Server.We identified 1,017 company-sponsored alcohol-brand related sites on Facebook™.Our study advances previous literature by providing a systematic overview of the extent of alcohol brand sites on Facebook™.

SUBMITTER: Nhean S

PROVIDER: S-EPMC4410775 | biostudies-literature | 2014 Jun

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

The frequency of company-sponsored alcohol brand-related sites on Facebook™-2012.

Nhean Siphannay S Nyborn Justin J Hinchey Danielle D Valerio Heather H Kinzel Kathryn K Siegel Michael M Jernigan David H DH

Substance use & misuse 20140205 7

<h4>Background</h4>This research provides an estimate of the frequency of company-sponsored alcohol brand-related sites on Facebook™.<h4>Objectives</h4>We conducted a systematic overview of the extent of alcohol brand-related sites on Facebook™ in 2012.<h4>Methods</h4>We conducted a 2012 Facebook™ search for sites specifically related to 898 alcohol brands across 16 different alcoholic beverage types. Descriptive statistics were produced using Microsoft SQL Server.<h4>Results</h4>We identified 1 ...[more]

PMID: 24499464

Similar Datasets

Project description:BackgroundDetails about the type of analysis (e.g., intent to treat [ITT]) and definitions (i.e., criteria for including participants in the analysis) are necessary for interpreting a clinical trial's findings. Our objective was to compare the description of types of analyses and criteria for including participants in the publication (i.e., what was reported) with descriptions in the corresponding internal company documents (i.e., what was planned and what was done). Trials were for off-label uses of gabapentin sponsored by Pfizer and Parke-Davis, and documents were obtained through litigation.Methods and findingsFor each trial, we compared internal company documents (protocols, statistical analysis plans, and research reports, all unpublished), with publications. One author extracted data and another verified, with a third person verifying discordant items and a sample of the rest. Extracted data included the number of participants randomized and analyzed for efficacy, and types of analyses for efficacy and safety and their definitions (i.e., criteria for including participants in each type of analysis). We identified 21 trials, 11 of which were published randomized controlled trials, and that provided the documents needed for planned comparisons. For three trials, there was disagreement on the number of randomized participants between the research report and publication. Seven types of efficacy analyses were described in the protocols, statistical analysis plans, and publications, including ITT and six others. The protocol or publication described ITT using six different definitions, resulting in frequent disagreements between the two documents (i.e., different numbers of participants were included in the analyses).ConclusionsDescriptions of analyses conducted did not agree between internal company documents and what was publicly reported. Internal company documents provide extensive documentation of methods planned and used, and trial findings, and should be publicly accessible. Reporting standards for randomized controlled trials should recommend transparent descriptions and definitions of analyses performed and which study participants are excluded.

Dataset Information

The frequency of company-sponsored alcohol brand-related sites on Facebook™-2012.

Publications

The frequency of company-sponsored alcohol brand-related sites on Facebook™-2012.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets